摘要
目的:探讨比索洛尔对顽固性心绞痛患者血清炎症因子的影响。方法:将84例顽固性心绞痛患者分为研究组和对照组,每组42例。对照组给予阿托伐他汀治疗。研究组采用比索洛尔联合阿托伐他汀治疗。对比两组的疗效并检测患者治疗前后血清炎症因子的水平变化。结果:研究组的疗效均明显优于对照组(P <0. 05);两组治疗后的血清炎症因子较治疗前均明显降低(P <0. 05);治疗后,研究组的血清炎症因子明显低于对照组(P <0. 05)。结论:比索洛尔联合阿托伐他汀能显著改善顽固性心绞痛患者的临床症状,降低炎症反应。
Objective: To investigate the effect of bisoprolol on serum inflammatory factors in patients with intractable angina pectoris. Methods: 84 patients with intractable angina pectoris were divided into the study group and the control group,42 cases in each group. The control group was treated with atorvastatin. The study group was treated with bisoprolol combined with atorvastatin. The efficacy of the two groups was compared and the levels of serum inflammatory factors were detected before and after treatment. Results: The curative effect of the study group was significantly better than that of the control group( P < 0. 05);the serum inflammatory factors of the two groups after treatment were significantly lower than those before treatment( P < 0. 05);after treatment,the serum inflammatory factors of the study group were significantly lower than those of the control group( P < 0. 05). Conclusion: Bisoprolol combined with atorvastatin can significantly improve the clinical symptoms of refractory angina pectoris and reduce inflammation.
作者
周张宁
Zhou Zhangning(Huzhou Central Hospital,Huzhou 313000,Zhejiang,China)
出处
《中国高等医学教育》
2018年第12期132-132,145,共2页
China Higher Medical Education
关键词
比索洛尔
顽固性心绞痛
炎症因子
bisoprolol
refractory angina pectoris
inflammatory factors
作者简介
周张宁,男,大学本科,住院医师,研究方向:全科医学。
